Wikipedia:Choosing Wisely/American Society for Clinical Pathology

The Choosing Wisely campaign will publish information from this society in late February 2013. Before then, there is no available information available except that this society is participating in the campaign and intends to share five ideas which its members have chosen as important for doctors and patients to discuss.

This project shares information from the American Society for Clinical Pathology on Wikipedia.

Articles of interest

edit
Articles relating to ASCP content
article traffic pageview count* example month example change sources cited change summary
American Society for Clinical Pathology chart 701 21 Nov 12
Bleeding time chart 11167 January 2013 [1] 5 "The bleeding time test is obsolete and not indicated when other more reliable and less invasive tests for determining coagulation are available."
Calcifediol chart 4819 January 2013 [2] 1 "(test) indicated in patients with high risk for vitamin D deficiency and when the results of the test would be used as supporting evidence for beginning aggressive therapies"
Clinical pathology chart 4812 21 Nov 12
Basic metabolic panel chart 16158 21 Nov 12
Comprehensive metabolic panel chart 18224 21 Nov 12
Human papillomavirus chart 186010 January 2013 [3] 2 "Patients with low risk HPV, however, have no indication for HPV testing."
Reference ranges for blood tests chart 67104 21 Nov 12
SEPT9 chart 260 January 2013 [4] 4 "Testing to detect methylated SEPT9 is not indicated as a first option for colorectal cancer screening"
Surgery chart 43066 January 2013 [5] 3 "tests including complete blood count, prothrombin time, partial thromboplastin time, basic metabolic panel, and urinalysis should not be done unless the results of these tests can help evaluate surgical risk"
  • *An arbitrary month has been chosen to present a count of pageviews. This month is neither the busiest nor slowest month, and this number seems typical for most articles in most months. Through the link anyone may check traffic in other months.

Recent changes

edit

Review changes to all of the articles in the above table by visiting this watchlist.

References

edit

American Society for Clinical Pathology, "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Society for Clinical Pathology, retrieved August 1, 2013, which cites

    • Sattar, N.; Welsh, P.; Panarelli, M.; Forouhi, N. G. (2012). "Increasing requests for vitamin D measurement: Costly, confusing, and without credibility". The Lancet. 379 (9811): 95–96. doi:10.1016/S0140-6736(11)61816-3. PMID 22243814.
    • Bilinski, K. L.; Boyages, S. C. (2012). "The rising cost of vitamin D testing in Australia: Time to establish guidelines for testing". The Medical Journal of Australia. 197 (2): 90. doi:10.5694/mja12.10561. PMID 22794049.
    • Lu, Chuanyi M. (May 2012). "Pathology consultation on vitamin D testing: Clinical indications for 25(OH) vitamin D measurement [Letter to the editor]". American Journal Clinical Pathology (137). American Society for Clinical Pathology: 831–832., which cites
      • Arya, S. C.; Agarwal, N. (2012). "Pathology Consultation on Vitamin D Testing: Clinical Indications for 25(OH) Vitamin D Measurement". American Journal of Clinical Pathology. 137 (5): 832. doi:10.1309/AJCP2GP0GHKQRCOE. PMID 22523224.
    • Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P.; Murad, M. H.; Weaver, C. M. (2011). "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline". Journal of Clinical Endocrinology & Metabolism. 96 (7): 1911–1930. doi:10.1210/jc.2011-0385. PMID 21646368.
    • Church, T. R.; Wandell, M.; Lofton–Day, C.; Mongin, S.; Blumenstein, B. A.; Allen, J. I.; Roesch, T.; Snover, D.; Day, R.; Ransohoff, D. F.; Poordad, F.; Lawitz, E. J.; McCone, J.; Shiffman, M. L.; Galler, G. W.; Lee, W. M.; Reindollar, R.; King, J. W.; Kwo, P. Y.; Ghalib, R. H.; Freilich, B.; Nyberg, L. M.; Zeuzem, S.; Poynard, T.; Vock, D. M.; Pieper, K. S.; Patel, K.; Tillmann, H. L.; Noviello, S.; Koury, K. (2010). "Prospective Clinical Validation of an Assay for Methylated SEPT9 DNA in Human Plasma as a Colorectal Cancer Screening Tool in Average Risk Men and Women ≥50 Years". Gastroenterology. 139 (1): 120–129.e18. doi:10.1053/j.gastro.2010.05.068.
    • Ahlquist, D. A.; Taylor, W. R.; Mahoney, D. W.; Zou, H.; Domanico, M.; Thibodeau, S. N.; Boardman, L. A.; Berger, B. M.; Lidgard, G. P. (2012). "The Stool DNA Test is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia". Clinical Gastroenterology and Hepatology. 10 (3): 272–277.e1. doi:10.1016/j.cgh.2011.10.008. PMID 22019796.
    • Lehman, C. M.; Blaylock, R. C.; Alexander, D. P.; Rodgers, G. M. (2001). "Discontinuation of the bleeding time test without detectable adverse clinical impact". Clinical chemistry. 47 (7): 1204–1211. PMID 11427450.
    • Peterson, P.; Hayes, T. E.; Arkin, C. F.; Bovill, E. G.; Fairweather, R. B.; Rock Jr, W. A.; Triplett, D. A.; Brandt, J. T. (1998). "The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article". Archives of Surgery. 133 (2): 134–139. doi:10.1001/archsurg.133.2.134. PMID 9484723.
    • Lind, S. E. (1991). "The bleeding time does not predict surgical bleeding". Blood. 77 (12): 2547–2552. PMID 2043759.
edit